# Zr-89 Cimzia PET Imaging Rheumatoid Arthritis

> **NCT03546335** · PHASE1 · SUSPENDED · sponsor: **Robert Flavell, MD, PhD** · enrollment: 10 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** 89Zr-DFO-CZP

## Key facts

- **NCT ID:** NCT03546335
- **Lead sponsor:** Robert Flavell, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-10-01
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Lapse in study funding.
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03546335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03546335, "Zr-89 Cimzia PET Imaging Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03546335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*